These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sarcoma and helper-specific RNA tumor virus subunits in transformed nonproducer mouse cells activated to produce virus by treatment with bromodeoxyuridine. Tsuchida N; Shih MS; Gilden RV; Hatanaka M J Virol; 1974 Nov; 14(5):1262-7. PubMed ID: 4139290 [TBL] [Abstract][Full Text] [Related]
4. Properties of 3T3 cells transformed by murine sarcoma virus in the absence of replicating murine leukemia helper virus. Bassin RH; Phillips LA; Kramer MJ; Haapala DK; Peebles PT; Nomura S; Fischinger PJ Bibl Haematol; 1973; 39():272-80. PubMed ID: 4130395 [No Abstract] [Full Text] [Related]
5. Clonal isolation of murine sarcoma virus (MSV): characterization of virus produced from transformed cells. Somers K; Kit S Virology; 1971 Dec; 46(3):774-85. PubMed ID: 4332977 [No Abstract] [Full Text] [Related]
6. Ribonucleic acid components of murine sarcoma and leukemia viruses. Maisel J; Klement V; Lai MM; Ostertag W; Duesberg P Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3536-40. PubMed ID: 4357879 [TBL] [Abstract][Full Text] [Related]
7. Transformation-defective virus mutants in a class of morphologic revertants of sarcoma virus transformed nonproducer cells. Greenberger JS; Anderson GR; Aaronson SA Cell; 1974 Aug; 2(4):279-86. PubMed ID: 4370517 [No Abstract] [Full Text] [Related]
8. Non-infectious intracisternal A-type particles in a sarcoma-positive, leukemia-negative mouse cell line transformed by murine sarcoma virus (MSV). Billiau A; Sobis H; Eyssen H; Van den Berghe H Arch Gesamte Virusforsch; 1973; 43(4):345-51. PubMed ID: 4362933 [No Abstract] [Full Text] [Related]
9. Studies on virus induction by 5-bromodeoxyuridine in nonproducer murine sarcoma virus-transformed 3T3 cells. Margalith M; Thornton H; Narconis R; Pinkerton H; Green M Virology; 1975 May; 65(1):27-39. PubMed ID: 49978 [No Abstract] [Full Text] [Related]
10. Partial purification of intracellular murine sarcoma-leukemia virus RNA species by membrane filtration. Tsuchida N; Bhaduri S; Raskas HJ; Green M Intervirology; 1973; 1(1):27-33. PubMed ID: 4129687 [No Abstract] [Full Text] [Related]
11. The subunits of murine sarcoma-leukaemia virus RNA. McCain B; Biswal N; Benyesh-Melnick M J Gen Virol; 1973 Jan; 18(1):69-74. PubMed ID: 4352955 [No Abstract] [Full Text] [Related]
16. Revertants of mouse cells transformed by murine sarcoma virus. II. Flat variants induced by fluordeoxyuridine and colcemid. Nomura S; Fischinger PJ; Mattern CF; Gerwin BI; Dunn KJ Virology; 1973 Nov; 56(1):152-63. PubMed ID: 4126841 [No Abstract] [Full Text] [Related]
17. Revertants of mouse cells transformed by murine sarcoma virus. I. Characterization of flat and transformed sublines without a rescuable murine sarcoma virus. Nomura S; Fischinger PJ; Mattern CF; Peebles PT; Bassin RH; Friedman GP Virology; 1972 Oct; 50(1):51-64. PubMed ID: 4117128 [No Abstract] [Full Text] [Related]
18. RNA tumor virus and reverse transcriptase. I. Biochemical studies on the ESP-1 particles. II. Role of the reverse transcriptase in murine RNA tumor virus. Wu AM; Ting RC; Yang SS; Gallo RC; Paran M Bibl Haematol; 1973; 39():506-17. PubMed ID: 4130399 [No Abstract] [Full Text] [Related]
19. Polypeptides of Moloney sarcoma-leukemia virions: their resolution and incorporation into extracellular virions. Witte ON; Weissman IL Virology; 1974 Oct; 61(2):575-87. PubMed ID: 4371461 [No Abstract] [Full Text] [Related]